metaLead Therapeutics ApS — Credit Rating and Financial Key Figures

metaLead Therapeutics ApS (CVR number: 44212765) is a company from Høje-Taastrup. The company recorded a gross profit of -1059.1 kDKK in 2025. The operating profit was -1163.1 kDKK, while net earnings were -1375 kDKK. The profitability of the company measured by Return on Assets (ROA) was -26.3 %, which can be considered poor and Return on Equity (ROE) was -141.5 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at -92.5 %. This indicates that the company's debt surpasses the value of its total assets, posing significant financial risk. metaLead Therapeutics ApS's liquidity measured by quick ratio was 15.7 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.